ATE460934T1 - Pharmazeutische zubereitungen von ciprofloxacin - Google Patents

Pharmazeutische zubereitungen von ciprofloxacin

Info

Publication number
ATE460934T1
ATE460934T1 AT06015012T AT06015012T ATE460934T1 AT E460934 T1 ATE460934 T1 AT E460934T1 AT 06015012 T AT06015012 T AT 06015012T AT 06015012 T AT06015012 T AT 06015012T AT E460934 T1 ATE460934 T1 AT E460934T1
Authority
AT
Austria
Prior art keywords
ciprofloxacin
pharmaceutical preparations
relates
present
precisely
Prior art date
Application number
AT06015012T
Other languages
English (en)
Inventor
Sami M A Qassim
Original Assignee
Tabuk Pharmaceutical Mfg Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tabuk Pharmaceutical Mfg Co filed Critical Tabuk Pharmaceutical Mfg Co
Application granted granted Critical
Publication of ATE460934T1 publication Critical patent/ATE460934T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT06015012T 2006-07-19 2006-07-19 Pharmazeutische zubereitungen von ciprofloxacin ATE460934T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06015012A EP1880722B1 (de) 2006-07-19 2006-07-19 Pharmazeutische Zubereitungen von Ciprofloxacin

Publications (1)

Publication Number Publication Date
ATE460934T1 true ATE460934T1 (de) 2010-04-15

Family

ID=37806079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06015012T ATE460934T1 (de) 2006-07-19 2006-07-19 Pharmazeutische zubereitungen von ciprofloxacin

Country Status (3)

Country Link
EP (1) EP1880722B1 (de)
AT (1) ATE460934T1 (de)
DE (1) DE602006012962D1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8759303B2 (en) 2010-06-07 2014-06-24 Telik, Inc. Compositions and methods for treating myelodysplastic syndrome
CA2797458A1 (en) 2010-06-07 2011-12-15 Telik, Inc. Tablet formulation of ezatiostat
US8841476B2 (en) 2010-06-07 2014-09-23 Telik, Inc. Preparation of crystalline ezatiostat hydrochloride ansolvate form D
CA2819967C (en) 2012-08-31 2016-03-22 Intermune, Inc. Use of pirfenidone concomitantly with ciprofloxacin
GR1008169B (el) * 2013-03-19 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
US20240325352A1 (en) * 2017-06-20 2024-10-03 Neurosense Therapeutics Ltd. Compositions Comprising an Anti-Inflammatory Drug and a Dicer Activator for use in the Treatment of Neuronal Diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN186245B (de) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
HU227070B1 (en) * 1999-08-11 2010-06-28 Egis Gyogyszergyar Nyilvanosan Immediate release pharmaceutical composition containing ciprofloxacin and process for its production
EA200200914A1 (ru) * 2000-03-03 2003-02-27 Рэнбакси Лабораториз Лимитед Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
EP1880722A1 (de) 2008-01-23
DE602006012962D1 (de) 2010-04-29
EP1880722B1 (de) 2010-03-17

Similar Documents

Publication Publication Date Title
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
UA94942C2 (ru) Фармацевтические композиции с ингибиторами dpp iv
NO20043367L (no) Oralt farmasoytisk preparat
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
PH12013502277A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
CY1113462T1 (el) Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο
EA201170512A1 (ru) Композиция для перорального введения
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
ATE354362T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
DE602004023093D1 (de) N mit einem abgabemittel in mikronisierter form
NO20071806L (no) Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel.
WO2005117895A8 (en) Compositions comprising meloxicam
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
SE0401655D0 (sv) New compounds
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
EA200500672A1 (ru) Содержащие альфузозин композиции с отсроченным высвобождением
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
ATE530172T1 (de) Pharmazeutische formulierungen mit clopidogrel
EA201290378A1 (ru) Композиции, содержащие нестероидные противовоспалительные лекарственные средства

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1880722

Country of ref document: EP